INTRASTENT DOUBLESTRUT STENT
Medtronic Vascular, Inc. · Decision date Jun 8, 2004
What did the FDA approve?
The FDA database records a 2004 approval for the IntraStent DoubleStrut Stent from Medtronic Vascular, Inc. The stated purpose is improving luminal diameter in patients with symptomatic atherosclerotic disease of the common and/or external iliac arteries up to 100 mm in length, with a reference vessel diameter of 5 to 10 mm.
The record identifies the device category as an iliac stent under product code NIO. The source statement reports the approved indication but does not include clinical data, safety outcomes, or effectiveness evidence. No supplement type or reason is listed, so this entry reflects the original approval scope rather than a change to it.
FDA approval order statement
APPROVAL FOR THE INTRASTENT DOUBLESTRUT STENT. THE DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC ATHEROSCLEROTIC DISEASE OF THE COMMON AND/OR EXTERNAL ILIAC ARTERIES UP TO 100 MM IN LENGTH, WITH A REFERENCE VESSEL DIAMETER OF 5 TO 10 MM.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 8, 2004
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P030045
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIO
- Decision code
- APPR
- Decision date
- Jun 8, 2004
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIO
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P030045 received
Application receipt date recorded by FDA.
P030045 · FDA decision
APPR
P030045/S011 · Related supplement
Visi-Pro balloon-Expandable peripheral stent system
Timeline entries are records held by MedtechLedger for P030045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
| Biotronik AG | PMA approval | Dec 17, 2015 | FDA | |
ZILVER VASCULAR STENTP050017 | Cook Ireland, Ltd. | PMA approval | Jun 26, 2006 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3033 Campus Dr., Plymouth, MN, 55441
Sources and methodology
- Original FDA record: P030045
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



